Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
J. Reeve, John T. Potts(National Institutes of Health), O. L. M. Bijvoet, F. J. F. E. Vismans, Pierre J. Meunier, J C Rénier, C Edouard, M Bernat, Robert M. Neer(Brigham and Women's Hospital), J. A. Parsons, P Courpron, L. Klenerman(University of Liverpool), David M. Slovik(Boston University)
Cited by 585
Related Papers
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
|The Lancet|2015|574
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
|The Lancet|2013|491
Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic Patients
|New England Journal of Medicine|1981|372
Decreased Bone Density in Hyperprolactinemic Women
|New England Journal of Medicine|1980|363